Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Effectiveness study (incl. comparative)

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cross-sectional
Other

Non-interventional study design, other

Non-interventional survey
Study drug and medical condition

Name of medicine

INSTANYL

Medical condition to be studied

Cancer pain
Population studied

Short description of the study population

Physicians prescribers, or potential prescribers, of Instanyl® who are targeted for the educational materials.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

267
Study design details

Main study objective

The objective of the survey is to measure the proportion of targeted physicians who received, understood and followed the safety information about Instanyl® provided in the updated educational materials.

Data analysis plan

Continuous variables will be described by the number of valid cases and missing data, mean, standard deviation, median, Q1, Q3, minimum, and maximum. No missing data will be replaced. Categorical variables will be described as the total number and relative percentage per category. Confidence intervals of 95% will be calculated when relevant.Calculations will first be performed on raw data per specialty, and weighted according to the real proportion of targeted physicians in each country to accurately reflect the population the survey seeks to measure. Possible selection bias will be assessed by comparing the distributions of available characteristics (e.g. region, age, gender, type of practice and specialty) between respondent and non-respondent physicians.
Documents
Study results
English (3.02 MB - PDF)View document